- Created by Scott Gordon, last modified on Sep 17, 2021
Short Description | The track will focus on extracting patient medication data from an EHR FHIR server and generating an SDTM dataset to submit to FDA's submission Gateway for validation. This is an evolution from the January track and new steps will cover the assessment of the confidence in the quality of the data and addition of a FHIR based algorithmic approach to consolidation of medication data for a patient. |
Long Description | Clinical Research studies currently require the redundant entry of clinical data that already typically reside in certified EHR/health IT systems. It would be substantially better to utilize EHR source data to directly populate clinical research data capture systems wherever feasible. At this time, the data standard used for submission of tabulated clinical study data for pharmaceutical and biologicals to the FDA is SDTM (Study Data Tabulation Model), created by the Clinical Data Interchange Standards Consortium (CDISC) standards development organization, which is optimized for clinical research and regulatory uses. This track is the third in a series evolving an approach to collect concomitant medication data for a patient from one or more EHR systems and to aggregate this into a summary record that meets regulatory standards for accuracy and trustworthiness and which can then be converted into a format for submission. The January 2021 considered a series of fictional patients, and retrieved retrieve medications relevant dates from the following resources: MedicationStatment; MedicationRequest. In May 2021, we expanded to allow retrieval from additional resources: MedicationDispense and MedicationAdministration and began to explore how best to represent a complete medical record set utilizing something more efficient than a FHIR bundle. Additionally explored how to represent additional supplemental Medication information in SDTM where such information is not normally stored in the core CM domain. For September we aim to expand on this to allow interrogation of source data with CapabilityStatement which should help all downstream decision-making for a reference implementation, improve data retrieval and consolidation of cross-resource medication information into a refined FHIR profile, achieve a level of deduplication, and improve the ultimate SDTM output to fully utilize the SUPPxx domain methodology. |
Type | Test the design of a set of resources, Test an Implementation Guide |
Submitting Work Group/Project/Accelerator/Affiliate/Implementer Group | Vulcan Accelerator |
Track Lead(s) | Scott Gordon, Lauren McCabe |
Track Lead Email(s) | Gideon.Gordon@fda.hhs.gov; Lauren.McCabe@pfizer.com |
Related Tracks |
|
FHIR Version | FHIR R4 is current primary focus, also US Core. However, since many other implementations exist, we are not limiting this exclusively. Further, as R5 moves forward in balloting, we will keep an eye on relevant changes. |
Specification(s) this track uses | Aim to have a 1st Draft Implementation Guide for this Connectathon |
Artifacts of focus | https://www.hl7.org/fhir/medicationrequest.html; https://www.hl7.org/fhir/medicationadministration.html; |
Expected participants | Vulcan members, Regulators, EHR Vendors, EDC Vendors, Academic Medical Centers, Pharma Companies. We averaged 10-15 participants in January and May - should be similar. We particularly invite EHR vendors to provide test systems to work with and Developers to address the medication record consolidation part of the system. |
Zulip stream | |
Kick-off Call | Tuesday September 7, 2021, 11:00 AM - 12:00 PM Eastern Time Whova Agenda and Webinar Link: https://whova.com/portal/webapp/hlsfh_202109/Agenda/1910218 |
Track Details | System Roles:
Scenario: The September scenario for a patient in the EHR FHIR server by a patient identifier
Test Script(s): The wireframe below shows the January/May reference implementation. For September it may be similar
Note: Other CDISC SDTM files necessary for the submission will be manually created, i.e. TS (Trial Summary), TE (Trial Elements), TA (Trial Arms), and define.xml. Since the server will have EHR clinical data, and no clinical trial data, the clinical trial related variable values used in these SDTM domain files will be synthetic and constant for any patient used in the prototype. Security and Privacy Considerations: The data used for this connectathon will be synthetic or fully anonymized. There may be security requirements for access tot the FDA gateway for testing. References:
|
Files and links during Connectathon | Kick-off session Slides (September 7, 2021): Concomitant query and bundle creation Module : Demo - Vulcan Medication Bundle (vulcan-medication-bundle.azurewebsites.net) Transformation Module (transform FHIR bundle to SDTM) Transform Bundle - FHIR 2 SDTM (mylinks-prod-sdtmtool.azurewebsites.net) Day 1 (Sept 14) 8am Slides: FHIR links for medication status filter activity: remove medication if the status tells us it was not or will not be taken.
Draft of decision algorithms based of Medication[x] Status field Draft identifying all elements of all Medication[x] resources which we recommend be implemented and utilized consistently (where relevant) in all EHRs in order to make concomitant medication determination more reliable. (There are absolutely strong pure healthcare justifications as well for these elements being present). MedicationX Resources and ConMed.docx |
1 Comment
Scott Gordon
Useful links for next connectathon:
UPDATED CDISC-FHIR Mapping
https://www.cdisc.org/standards/real-world-data/fhir-cdisc-joint-mapping-implementation-guide-v1-0
LZZT Study protocol
This is the LZZT protocol, https://wiki.ihe.net/images/4/47/Lzzt_protocol_redacted.pdf Lilly donated it years ago. There is a database of the SDTM on GitHub - Transcelerate - not sure who (?); CDISC has it on the website years ago but it is no longer there.
(UPDATED link) FHIRLOINC2SDTM
Brought to you by: xml4pharma
Software workup created by Jozef Aerts, covers many aspects of EHR -→ SDTM